RIBOZYME AND OMICS

고객지원

News

[CEO Interview] Rznomics aims to serve two ends via RNA replacement

  • 작성자
    관리자
  • 날짜
    2022-10-26
기사원문
[CEO Interview] Rznomics aims to serve two ends via RNA replacement
[CEO Interview] Rznomics aims to serve two ends via RNA replacement

Original article: hankyung BIO Insight October 2022
PREV
RZNOMICS Inc. received FDA approval to initiate clinical development of trans-sp...
LIST
LIST
NEXT
[Journal publish]Pros and Cons of In Vitro Methods for Circular RNA Preparation